Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of Posology Adaptation of Irbesartan in Ambulatory Hypertensive Patients

NCT00283036 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00283036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00283036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of Posology Adaptation of Irbesartan in Ambulatory Hypertensive Patients
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2005
Completion date
Not reported
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension